171 related articles for article (PubMed ID: 35488386)
21. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
22. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
25. Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy.
Horton C; Davies TJ; Lahiri P; Sachamitr P; Fairchild PJ
Stem Cells; 2020 Jan; 38(1):67-79. PubMed ID: 31621975
[TBL] [Abstract][Full Text] [Related]
26. The Construction and Identification of Induced Pluripotent Stem Cells Derived from Acute Myelogenous Leukemia Cells.
Zhu LF; Chen QR; Chen SZ; Wang LY; Luo XF; Ren JH; Yuan XH; Wu XQ; Zeng YL; Xiao M; Chen YQ; Chen YY; Lin MH; Wu ZJ; Chen ZZ; Hu JD; Yang T
Cell Physiol Biochem; 2017; 41(4):1661-1674. PubMed ID: 28359056
[TBL] [Abstract][Full Text] [Related]
27. Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures.
Franciosa G; Smits JGA; Minuzzo S; Martinez-Val A; Indraccolo S; Olsen JV
Nat Commun; 2021 May; 12(1):2507. PubMed ID: 33947863
[TBL] [Abstract][Full Text] [Related]
28. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
[TBL] [Abstract][Full Text] [Related]
29. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
[TBL] [Abstract][Full Text] [Related]
30. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice.
Zhang H; Cheng H; Wang Y; Zheng Y; Liu Y; Liu K; Xu J; Hao S; Yuan W; Zhao T; Cheng T
Blood Cancer J; 2016 Jul; 6(7):e444. PubMed ID: 27391576
[No Abstract] [Full Text] [Related]
32. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
[TBL] [Abstract][Full Text] [Related]
33. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.
Tucker BA; Anfinson KR; Mullins RF; Stone EM; Young MJ
Stem Cells Transl Med; 2013 Jan; 2(1):16-24. PubMed ID: 23283489
[TBL] [Abstract][Full Text] [Related]
34. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC
JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408
[TBL] [Abstract][Full Text] [Related]
35. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
Chao HM; Chern E
J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
[TBL] [Abstract][Full Text] [Related]
36. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
37. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
Yoshihara M; Hayashizaki Y; Murakawa Y
Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
[TBL] [Abstract][Full Text] [Related]
38. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
[TBL] [Abstract][Full Text] [Related]
39. Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia.
Kaushik B; Pal D; Saha S
Curr Drug Targets; 2021; 22(15):1789-1798. PubMed ID: 33538669
[TBL] [Abstract][Full Text] [Related]
40. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.
Ohnuki M; Tanabe K; Sutou K; Teramoto I; Sawamura Y; Narita M; Nakamura M; Tokunaga Y; Nakamura M; Watanabe A; Yamanaka S; Takahashi K
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12426-31. PubMed ID: 25097266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
